Cargando…

Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet?

Detalles Bibliográficos
Autores principales:	Peikert, Tobias, Bartholmai, Brian J., Maldonado, Fabien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365373/ https://www.ncbi.nlm.nih.gov/pubmed/32383972 http://dx.doi.org/10.1164/rccm.202004-1279ED

Ejemplares similares

Do we need to see to believe?—radiomics for lung nodule classification and lung cancer risk stratification
por: Khawaja, Ali, et al.
Publicado: (2020)

Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial
por: Peikert, Tobias, et al.
Publicado: (2018)

Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial
por: Peikert, Tobias, et al.
Publicado: (2018)

Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas
por: Clay, Ryan, et al.
Publicado: (2017)

Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules
por: Paez, Rafael, et al.
Publicado: (2023)

Critical analysis of molecular tests in indeterminate thyroid nodules
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Evaluation of Computer-Aided Nodule Assessment and Risk Yield (CANARY) in Korean patients for prediction of invasiveness of ground-glass opacity nodule
por: Lee, Juyoung, et al.
Publicado: (2021)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Quantitative Stratification of Diffuse Parenchymal Lung Diseases
por: Raghunath, Sushravya, et al.
Publicado: (2014)

Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas
por: Nakajima, Erica C., et al.
Publicado: (2018)

Defining the Clinical Utility of the Lung Clearance Index. Are We There Yet?
por: Spano, Jacquelyn, et al.
Publicado: (2021)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Radiomics analysis improves (18)FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2021)

Computed-tomography-based radiomic nomogram for predicting the risk of indeterminate small (5–20 mm) solid pulmonary nodules
por: Zhang, Chun-Ran, et al.
Publicado: (2023)

Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020)

Value of Information Analysis: Are We There Yet?
por: Tuffaha, Haitham
Publicado: (2020)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

The COVID‐19 world – Are we there yet?
por: Hamamoto, Yoshiyuki
Publicado: (2021)

Cost effectiveness of intraoperative pathology in the management of indeterminate thyroid nodules
por: Vuong, Christopher D., et al.
Publicado: (2020)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

Comparison of Thyroid Imaging Reporting and Data Systems in Malignancy Risk Stratification of Indeterminate Thyroid Nodules
por: Kim, Bo Hyun
Publicado: (2021)

A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules
por: Rundo, Leonardo, et al.
Publicado: (2021)

Capacity building in endometriosis ultrasound: are we there yet?
por: Menakaya, Uche A
Publicado: (2015)

Digital future in perioperative medicine: Are we there yet?
por: Panchagnula, Umakanth, et al.
Publicado: (2019)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

Radiofrequency ablation for primary hyperparathyroidism: are we there yet?
por: McManus, Catherine
Publicado: (2023)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
por: Allen, Laura, et al.
Publicado: (2019)

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules
por: Vachani, Anil, et al.
Publicado: (2015)

The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
por: Jooya, Alborz, et al.
Publicado: (2016)

Reducing uncertainty to a manageable level: the need for a nuanced and patient-centric approach to lung nodule management in the 21(st) century
por: Maldonado, Fabien, et al.
Publicado: (2020)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Indeterminate thyroid nodules in the era of molecular genomics
por: Rao, Sarika N., et al.
Publicado: (2020)

Local molecular analysis of indeterminate thyroid nodules
por: Gill, Mandeep S., et al.
Publicado: (2015)

Indeterminate nodules in osteosarcoma: what’s the follow-up?
por: Ghosh, K M, et al.
Publicado: (2018)

A Pragmatic Approach to the Indeterminate Thyroid Nodule
por: Seshadri, Krishna G.
Publicado: (2017)

Are we there yet? Pushing the boundaries of endonasal surgery into the brainstem
por: Cohen-Gadol, Aaron A.
Publicado: (2020)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Abandoned embryos in Brazil: advances in the decisions. Are we there yet?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rjdl9208l4do3gufnon0vje58s